Rescue Therapy Use in Patients with Diabetic Macular Edema (DME) Receiving Intravitreal Aflibercept (IVT-AFL) or Laser: Results from the VIVID-DME and VISTA-DME Trials

被引：0
|
作者：
Rehak, Matus [1 ]
Korobelnik, Jean-Francois [2 ]
Metzig, Carola [3 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Hop Pellegrin, F-33076 Bordeaux, France
[3] Bayer Healthcare, Berlin, Germany
来源：
OPHTHALMOLOGICA | 2014年 / 232卷
关键词：
Diabetic Macular Edema; Rescue Therapy; Diabetic Retinopathy; Anti-Vascular Endothelial Growth Factor; Aflibercept;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
147
引用
收藏
页码：17 / 18
页数：2
相关论文
共 46 条
  • [41] The use of intravitreal implant ILUVIEN ® (fluocinolone acetonide) after prior OZURDEX ® Implant (DEX) (Dexamathason) in patients with diabetic macular edema (DME) - Efficacy and safety outcomes from the University Eye Clinic in Frankfurt, Germany
    Singh, Pankaj
    Chedid, Adonis
    Deuchler, Svenja
    Kohnen, Thomas
    Mueller, Michael
    Koch, Frank H. J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [42] Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study
    Svenja K. Deuchler
    Ralf Schubert
    Pankaj Singh
    Adonis Chedid
    Ninel Kenikstul
    Julia Scott
    Thomas Kohnen
    Hanns Ackermann
    Frank Koch
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2537 - 2547
  • [43] Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study
    Deuchler, Svenja K.
    Schubert, Ralf
    Singh, Pankaj
    Chedid, Adonis
    Kenikstul, Ninel
    Scott, Julia
    Kohnen, Thomas
    Ackermann, Hanns
    Koch, Frank
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (08) : 2537 - 2547
  • [44] Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN® (0.19 mg fluocinolone acetonide implant)
    Augustin, Albert J.
    Bopp, Silvia
    Fechner, Martin
    Holz, Frank
    Sandner, Dirk
    Winkgen, Andrea-M
    Khoramnia, Ramin
    Neuhann, Thomas
    Warscher, Marcus
    Spitzer, Martin
    Sekundo, Walter
    Seitz, Berthold
    Duncker, Tobias
    Ksinsik, Christian
    Hoeh, Helmuth
    Gentsch, Daniela
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (02) : 382 - 391
  • [45] Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study
    Massin, Pascale
    Creuzot-Garcher, Catherine
    Kodjikian, Laurent
    Girmens, Jean-Francois
    Delcourt, Cecile
    Fajnkuchen, Frank
    Glacet-Bernard, Agnes
    Guillausseau, Pierre-Jean
    Ponthieux, Anne
    Blin, Patrick
    Grelaud, Angela
    OPHTHALMIC RESEARCH, 2019, 62 (02) : 101 - 110
  • [46] Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study
    Garcher, Catherine P. Creuzot
    Massin, Pascale
    Kodjikian, Laurent
    Girmens, Jean-Francois
    DelCourt, Cecile
    Fajnkuchen, Frank
    Glacet, Agnes
    Guillausseau, Pierre-Jean
    Derveloy, Audrey
    Finzi, Laetitia
    Blin, Patrick
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345